Recent Company News

• 09:19 AM ET Oct 24, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 04:08 AM ET Nov 24, 2025
  

  Genenta updates on TEM-GBM study of Temferon ($1.68, 0.00)

• 08:19 AM ET Jul 01, 2025
  

  StreetAccount Summary - US Pre-market trading

• 08:32 PM ET Oct 26, 2025
  

  Genenta Science enters into securities purchase agreement with institutional investors to purchase 4.3M ADSs at $3.50/ADS ($6.20, 0.00)

• 04:02 AM ET Oct 24, 2025
  

  Genenta, Anemocyte form new strategic partnership; terms undisclosed ($3.23, 0.00)

• 05:02 AM ET Jul 01, 2025
  

  Genenta Science updates on TEM-GBM, TEM-LT, TEM-GU studies of Temferon ($3.05, 0.00)